XML 46 R26.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Calculation of basic and diluted net (loss) income per common stock (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Numerator:            
Allocation of net (loss) income $ (1,744,000) $ (8,093,000) $ (26,968,000) $ (24,645,000) $ (50,016,000) $ (28,845,000)
Denominator:            
Weighted average shares outstanding, basic 13,173,422 311,823 4,749,849 299,936 309,609 219,100
Weighted average shares outstanding, diluted 13,173,422 311,823 4,749,849 299,936 309,609 219,100
Basic net (loss) income per share $ (0.13) $ (25.95) $ (5.68) $ (82.17) $ (161.55) $ (131.65)
Diluted net (loss) income per share $ (0.13) $ (25.95) $ (5.68) $ (82.17) $ (161.55) $ (131.65)
MedTech Acquisition Corp | Class A Common Stock            
Numerator:            
Allocation of net (loss) income         $ 4,369,839 $ 3,813,826
Denominator:            
Weighted average shares outstanding, basic         23,358,326 25,000,000
Weighted average shares outstanding, diluted         23,358,326 25,000,000
Basic net (loss) income per share         $ 0.19 $ 0.15
Diluted net (loss) income per share         $ 0.19 $ 0.15
MedTech Acquisition Corp | Class B Common Stock            
Numerator:            
Allocation of net (loss) income         $ 1,169,240 $ 953,457
Denominator:            
Weighted average shares outstanding, basic         6,250,000 6,250,000
Weighted average shares outstanding, diluted         6,250,000 6,250,000
Basic net (loss) income per share         $ 0.19 $ 0.15
Diluted net (loss) income per share         $ 0.19 $ 0.15